Categories
Shaily Engineering Plastics Limited — Updates, 20-05-2026: Press Release
20-05-2026 · 03:16 pm
Shaily announced its ShailyPen Neo™ device received key regulatory approvals for a generic Semaglutide injection. The product, launched in Canada and available in India, highlights Shaily's pivotal role in advanced drug delivery systems and expands its market footprint.
No comments yet. Be the first to comment!